Since 2018 – Coordinator of the Biochemical Genetics Laboratory, CGM, CHUP
From 2012-2018 – Coordination of Congenital Disorders of Glycosylation diagnosis

From 2008 to 2012 – Coordinator of the Clinical Biology Laboratory of the Biochemical Genetics Unit

From 1997 to 2008 – Developed work in the Inborn Errors of Metabolism diagnostic Clinical Biology Laboratory

From 1992 to 1997 – Developed work in the Peroxisomal Disorders post and Prenatal diagnostic

2003 – Trained biochemical and molecular diagnostic in the Congenital Disorders of Glycosylation in the Metabolic Department of University Hospital Gasthuisberg in Leuven, Belgium, by Prof. Dr. Jaak Jaeken

2000 – Trained in the molecular diagnostic of Congenital Disorders of Glycosylation in the Laboratory for Molecular Diagnosis of the Department of Human Genetics of KU Leuven, Belgium, by Prof..Dr Gert Matthijs

1998 – Trained in the biochemical diagnostic of Congenital Disorders of Glycosylation in the Metabolic Department of University Hospital Gasthuisberg in Leuven, Belgium, by Prof. Dr. Jaak Jaeken

Recognised by the European Board of Medical Genetics with the title of Certified Clinical Laboratory Geneticists (general) until 2025 (https://www.eshg.org/667.0.html)

Curso de formação contínua: Genética médica e laboratorial (GML)
Instituto de Ciências Biomédicas Abel Salazar, University of Porto
2014-2018

Introdução à Medicina
Mestrado Integrado em Medicina
Instituto de Ciências Biomédicas Abel Salazar, University of Porto
2019-2121

POCI-01-0145-FEDER-29723 with the title “Do genótipo ao fenótipo: avaliando os efeitos epistáticos entre as mutações e os polimorfismos nas doenças genéticas”
Main institution: Ipatimup
PI: Luísa Azevedo, PhD
Dulce Quelhas: participates with a 25% dedication

GLY – clinical and basic investigation into phosphomannomutase deficiency (PMM2-CDG)
Promoter: Glycomine
Partner institution: Centro Hospitalar Universitário do Porto
PI: Esmeralda Martins, MD, PhD

PI21/00068, Instituto de Salud Carlos III
Stroke-like episodes in CDG: An international multicenter approach to discover the real phenotype, improve the diagnosis and management and understand the underlying mechanisms.
PI: Mercedes Serrano, MD, PhD

Member of the Scientific Committee of the Portuguese Society of Human Genetics from 2009-2010
Member of the director board of Portuguese Society of Metabolic Disorders since 2012
Council member of the director board of Society for the Study of Inborn Errors of Metabolism (SSIEM) since September 2017
Scientific Advisor of European Research Network for evaluation and improvement of screening, Diagnosis and treatment of Inborn errors of Metabolism (ERNDIM)

Reviewer for European Journal of Human Genetics in 2013, 2014, 2015, 2021
Reviewer for The Journal of Inherited Metabolic Disease in 2016, 2017, 2020, 2021